EnzMed is a biopharmaceutical company dedicated to the research, development, manufacturing and marketing of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and biochemical reagents. Through its integrated chiral technology platform that combines biotransformation and asymmetric synthesis, EnzMed offers novel and cost-effective solutions to pharmaceutical process development and manufacturing of chiral APIs.

EnzMed (Nanjing) Co., Ltd. is based in Nanjing Economic and Technological Development Zone, Nanjing, China.